By Frank Prenesti
Date: Monday 27 Jan 2020
(Sharecast News) - AstraZeneca said it had agreed to sell the global commercial rights to a range of hypertension treatments to Atnahs Pharma for up to $390m.
By Abigail Townsend
Date: Tuesday 05 Nov 2019
(Sharecast News) - Botox maker Allergan, which is being taken over in a $63bn blockbuster deal, has upped its full-year guidance after posting a forecast-beating set of third-quarter numbers.
By Iain Gilbert
Date: Tuesday 25 Jun 2019
(Sharecast News) - Chicago-based biopharmaceutical company Abbvie snapped up Botox-maker Allergan for roughly $63bn on Tuesday, mostly in cash.
Currency | US Dollars |
Share Price | $ 188.39 |
Change Today | $ -0.90 |
% Change | -0.47 % |
52 Week High | $216.66 |
52 Week Low | $164.99 |
Volume | 3,058,671 |
Shares Issued | 1,765.26m |
Market Cap | $332,548m |
Beta | 0.44 |
RiskGrade | 122 |
Strong Buy | 6 |
Buy | 11 |
Neutral | 9 |
Sell | 0 |
Strong Sell | 0 |
Total | 26 |
Time | Volume / Share Price |
12:49 | 222 @ $188.39 |
12:48 | 100 @ $188.35 |
12:48 | 100 @ $188.38 |
12:48 | 100 @ $188.36 |
12:48 | 100 @ $188.40 |
You are here: research